Rapamycin with Antiretroviral Therapy in AIDS-Associated Kaposi Sarcoma: An AIDS Malignancy Consortium Study

PURPOSE: The mammalian target of rapamycin (mTOR) is activated in Kaposi sarcoma (KS) and its inhibitor, rapamycin, has induced KS regression in transplant-associated KS. This study aimed to evaluate rapamycin's safety and toxicity in HIV-infected individuals with KS receiving antiretroviral th...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Krown, Susan E., Roy, Debasmita, Lee, Jeannette Y., Dezube, Bruce J., Reid, Erin G., Venkataramanan, Raman, Han, Kelong, Cesarman, Ethel, Dittmer, Dirk P.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: 2012
Onderwerpen:
Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3302934/
https://ncbi.nlm.nih.gov/pubmed/22067664
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0b013e31823e7884
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items